Identification of multiple genetic loci that regulate adenovirus gene therapy

Gene Therapy

Volumn 11, Issue 1, 2004, Pages 4-14

  Zhang, H G ^a,b   Hsu, H C ^a   Yang, P A ^a   Yang, X ^a   Wu, Q ^a   Liu, Z ^a   Yi, N ^c   Mountz, J D ^a,b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adenovirus; BXD mice; Cytotoxic T cells; Genetics linkage analysis

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; GAMMA INTERFERON; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD ANALYSIS; CHROMOSOME 11; CHROMOSOME 15; CHROMOSOME 18; CHROMOSOME 19; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME 9; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCUS; GENE THERAPY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC REGULATION; IMMUNE RESPONSE; LYMPHOCYTOPOIESIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW; STRAIN DIFFERENCE; TIME; X CHROMOSOME;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; BREEDING; CHROMOSOME MAPPING; COMPUTATIONAL BIOLOGY; CYTOKINES; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GENOTYPE; IMMUNITY, NATURAL; LIVER; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; QUANTITATIVE TRAIT LOCI; T-LYMPHOCYTES, CYTOTOXIC;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES;

EID: 0742334476     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302136     Document Type: Review

References (64)

1. Liu Q, Muruve DA. Molecular basis of the inflammatory response to adenovirus vectors. Gene Therapy 2003; 10: 935-940.
2. Chirmule N et al. Immune responses to adenovirus and adeno-associated virus in humans. Gene Therapy 1999; 6: 1574-1583.
3. Michou AI et al. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Therapy 1997; 4: 473-482.
4. St George JA. Gene therapy progress and prospects: adenoviral vectors. Gene Therapy 2003; 10: 1135-1141.
5. Wickham TJ. Targeting adenovirus. Gene Therapy 2000; 7: 110-114.
6. Parks R, Evelegh C, Graham F. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration. Gene Therapy 1999; 6: 1565-1573.
7. Roth MD et al. Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses. J Immunol 2002; 169: 4651-4656.
8. Yang Y, Li Q, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995; 69: 2004-2015.
9. Yang Y, Wilson JM. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J Immunol 1995; 155: 2564-2570.
10. Kim M, Kim K. Diversity and complexity of CD8+ T cell responses against a single epitope of adenovirus E1B. Virology 2002; 295: 238-249.
11. Cichon G, Strauss M. Transient immunosuppression with 15-deoxyspergualin prolongs reporter gene expression and reduces humoral immune response after adenoviral gene transfer. Gene Therapy 1998; 5: 85-90.
12. Ye X et al. Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse. Gene Therapy 2000; 7: 1761-1767.
13. Minter RM et al. TNF-alpha receptor signaling and IL-10 gene therapy regulate the innate and humoral immune responses to recombinant adenovirus in the lung. J Immunol 2000; 164: 443-451.
14. Shean MK et al. Immunomodulation and adenoviral gene transfer to the lungs of nonhuman primates. Hum Gene Therapy 2000; 11: 1047-1055.
15. Zhang HG et al. Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver. Hum Gene Ther 1998; 9: 1875-1884.
16. Yang Y, Wilson JM. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 1996; 273: 1862-1864.
17. Schowalter DB et al. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression. Gene Therapy 1997; 4: 853-860.
18. Scaria A et al. Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway. Gene Therapy 1997; 4: 611-617.
19. Guerette B et al. Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig. Hum Gene Ther 1996; 7: 1455-1463.
20. Ziller C, Stoeckel F, Boon L, Haegel-Kronenberger H. Transient blocking of both B7.1 (CD80) and B7.2 (CD86) in addition to CD40-CD40L interaction fully abrogates the immune response following systemic injection of adenovirus vector. Gene Therapy 2002; 9: 537-546.
21. Zhang HG et al. Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells. Nat Biotechnol 1998; 16: 1045-1049.
22. Zhang HG et al. Hepatic DR5 induces apoptosis and limits adenovirus gene therapy product expression in the liver. J Virol 2002; 76: 5692-5700.
23. Hsu HC et al. Age-related change in thymic T-cell development is associated with genetic loci on mouse chromosomes 1, 3, and 11. Mech Ageing Dev 2002; 123: 1145-1158.
24. Hsu H-C et al, Age-related thymic involution in C57BL/6J × DBA/2J recombinant inbred mice maps to mouse chromosomes 9 and 10. Genes Immun 2003, (in press).
25. Schirrmacher V, Landolfo S, Zawatzky R, Kirchner H. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. II. Influence of minor histocompatibility antigens on tumor resistance, gamma-interferon induction and cytotoxic response. Invasion Metastasis 1981; 1: 175-194.
26. Grizzle WE et al. BXD recombinant inbred mice represent a novel T cell-mediated immune response tumor model. Int J Cancer 2002; 101: 270-279.
27. Libert C et al. Identification of a locus on distal mouse chromosome 12 that controls resistance to tumor necrosis factor-induced lethal shock. Genomics 1999; 55: 284-289.
28. Lee SH et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 2001; 28: 42-45.
29. Scalzo AA et al. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol 1992; 149: 581-589.
30. Vassalli G. Gene therapy of heart transplantation. Rev Med Suisse Romande 2002; 122: 145-148.
31. Acsadi G et al. Interferons impair early transgene expression by adenovirus-mediated gene transfer in muscle cells. J Mol Med 1998; 76: 442-450.
32. Manly KF, Olson JM. Overview of QTL mapping software and introduction to map manager QT. Mamm Genome 1999; 10: 327-334.
33. Manly KF, Cudmore Jr RH, Meer JM. Map Manager QTX, cross-platform software for genetic mapping. Mamm Genome 2001; 12: 930-932.
34. Chesler EJ et al. Genetic correlates of gene expression in recombinant inbred strains: a relational model to explore for neurobehavioral phenotypes. Neuroinformatics 2003, (in press).
35. Wang J, Williams RW, Chesler EJ, Manly KF. WebQTL: web-based complex trait analysis. Neuroinformatics 2003, (in press).
36. Benihoud K, Yeh P, Perricaudet M. Adenovirus vectors for gene delivery. Curr Opin Biotechnol 1999; 10: 440-447.
37. Burgert HG et al. Subversion of host defense mechanisms by adenoviruses. Curr Top Microbiol Immunol 2002; 269: 273-318.
38. Peng Y, Falck-Pedersen E, Elkon KB. Variation in adenovirus transgene expression between BALB/c and C57BL/6 mice is associated with differences in interleukin-12 and gamma interferon production and NK cell activation. J Virol 2001; 75: 4540-4550.
39. Doerschug K et al. First-generation adenovirus vectors shorten survival time in a murine model of sepsis. J Immunol 2002; 169: 6539-6545.
40. Wheeler MD et al. Adenoviral gene delivery can inactivate Kupffer cells: role of oxidants in NF-kappaB activation and cytokine production. J Leukoc Biol 2001; 69: 622-630.
41. Matsuki Y et al. Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-alpha production by Kupffer cells. Cell Death Differ 2002; 9: 626-635.
42. Qin L et al. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther 1997; 8: 2019-2029.
43. Smith HR et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 2002; 99: 8826-8831.
44. Blake JA, Richardson JE, Davisson MT, Eppig JT. The Mouse Genome Database (MGD). A comprehensive public resource of genetic, phenotypic and genomic data. The Mouse Genome Informatics Group. Nucleic Acids Res 1997; 25: 85-91.
45. Blake JA et al. MGD: the Mouse Genome Database. Nucleic Acids Res 2003; 31: 193-195.
46. Havelkova H et al. T-cell proliferative response is controlled by loci Tria4 and Tria5 on mouse chromosomes 7 and 9. Mamm Genome 1999; 10: 670-674.
47. Panoutsakopoulou V et al. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice. J Immunol 1998; 161: 17-26.
48. Otto JM et al. Identification of multiple loci linked to inflammation and autoantibody production by a genome scan of a murine model of rheumatoid arthritis. Arthritis Rheum 1999; 42: 2524-2531.
49. Butterfield RJ et al. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J Immunol 1998; 161: 1860-1867.
50. Silveira PA et al. Identification of the Gasa3 and Gasa4 autoimmune gastritis susceptibility genes using congenic mice and partitioned, segregative and interaction analyses. Immunogenetics 2001; 53: 741-750.
51. McIndoe RA et al. Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice. Proc Natl Acad Sci USA 1999; 96: 2210-2214.
52. Daser A et al. Genetics of atopy in a mouse model: polymorphism of the IL-5 receptor alpha chain. Immunogenetics 2000; 51: 632-638.
53. Bachy M, Bonnin-Rivalland A, Tilliet V, Trannoy E. Beta galactosidase release as an alternative to chromium release in cytotoxic T-cell assays. J Immunol Methods 1999; 230: 37-46.
54. Ichikawa K et al. TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis. J Immunol 2003; 171: 1061-1069.
55. Williams RW, Go J, Qi S, Lu L. The genetic structure of recombinant inbred mice: high-resolution consensus maps for complex trait analysis. Genome Biol 2001; 2:RESEARCH0046.
56. Williams RW, Go J, Qi S, Lu L. Release 1 of the BXN Genotype Database: the genetic structure of recombinant inbred mice: high-resolution consensus maps for complex trait analysis. 2001.
57. Taylor BA et al. Genotyping new B x Drecombinant inbred mouse strains and comparison of B x Dand consensus maps. Mamm Genome 1999; 10: 335-348.
58. Laird PW et al. Simplified mammalian DNA isolation procedure. Nucleic Acids Res 1991; 19: 4293.
59. Dietrich W et al. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 1992; 131: 423-447.
60. Dietrich WF et al. A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nat Genet 1994; 7: 220-245.
61. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-247.
62. Churchill GA, Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics 1994; 138: 963-971.
63. Lynch M, Walsh B. Genetics and Analysis of Quantitative Traits. Sinauer: Sunderland, MA, 1998.
64. Belknap JK et al. Type I and type II error rates for quantitative trait loci (QTL) mapping studies using recombinant inbred mouse strains. Behav Genet 1996; 26: 149-160.